QT Imaging Holdings, Inc. (QTI)
| Market Cap | 45.23M -36.2% |
| Revenue (ttm) | 26.43M +220.0% |
| Net Income | -20.42M |
| EPS | -1.57 |
| Shares Out | 14.64M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 56,094 |
| Open | 3.160 |
| Previous Close | 3.120 |
| Day's Range | 2.950 - 3.200 |
| 52-Week Range | 2.510 - 8.500 |
| Beta | -0.01 |
| Analysts | Strong Buy |
| Price Target | 11.60 (+275.41%) |
| Earnings Date | Aug 12, 2026 |
About QTI
QT Imaging Holdings, Inc. engages in the research, development, and commercialization of body imaging systems with low frequency sound waves for detection, diagnosis, and treatment of diseases in the United States and Internationally. The company offers QT Breast Scanner, an ultrasonic imaging system that provides reflection-mode and transmission-mode images of a patient’s breast. It serves patients, medical professionals, and radiologists. The company has a collaboration with Olea Medical S.A.S for the development of QTI Imaging-Olea Viewer; a... [Read more]
Financial Performance
In 2025, QT Imaging Holdings's revenue was $18.93 million, an increase of 287.89% compared to the previous year's $4.88 million. Losses were -$21.08 million, 48.8% more than in 2024.
Financial StatementsAnalyst Summary
According to 2 analysts, the average rating for QTI stock is "Strong Buy." The 12-month stock price target is $11.6, which is an increase of 275.41% from the latest price.
News
QT Imaging issues mid-year letter to shareholders
QT Imaging (QTI) Holdings issued a mid-year 2026 letter to shareholders from its CEO, Dr. Raluca Dinu. “I am energized by QT Imaging’s many accomplishments so far in 2026, with…
QT Imaging Issues Mid-Year 2026 CEO Letter to Shareholders
NOVATO, Calif.--(BUSINESS WIRE)---- $QTI #BreastCancer--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health manage...
QT Imaging reports Q2 EPS (8c) vs. (8c) last year
Reports Q2 revenue $7.4M, two estimates $7.6M, “Our second quarter results demonstrate continued execution and the growing commercial momentum of QT Imaging (QTI). Revenue more than doubled year-over-...
QT Imaging Holdings Earnings Call Transcript: Q2 2026
Q2 2026 saw 103% revenue growth year-over-year, driven by strong scanner shipments and expanding U.S. and international presence. Gross margin was 41%, with net loss impacted by a non-cash debt modification charge. 2026 revenue guidance of $39M was affirmed, with continued focus on commercial adoption and operational scaling.
QT Imaging Holdings Quarterly report: Q2 2026
QT Imaging Holdings has published its Q2 2026 quarterly earnings report on August 12, 2026.
QT Imaging Holdings Earnings release: Q2 2026
QT Imaging Holdings released its Q2 2026 earnings on August 12, 2026, summarizing the period's financial results.
QT Imaging Delivers Strong Second Quarter Growth While Building the Foundation for Commercial Scale
NOVATO, Calif.--(BUSINESS WIRE)---- $QTI #BreastCancer--QT Imaging Holding, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health managem...
QT Imaging Holdings Slides: Investor presentation
QT Imaging Holdings has posted slides in relation to its latest quarterly earnings report, which was published on August 12, 2026.
QT Imaging to Report Second Quarter 2026 Financial Results and Host Conference Call on August 12, 2026
NOVATO, Calif.--(BUSINESS WIRE)---- $QTI #BreastCancer--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health manage...
QT appoints Dyer as VP Regional Sales East, Reinhart VP Regional Sales West
QT Imaging (QTI) advanced the direct U.S. commercial strategy for its Breast Acoustic CT Scanner with the appointment of Jason Dyer as Vice President, VP, Regional Sales East and Dave…
QT Imaging Advances Direct U.S. Commercial Strategy to Accelerate Adoption of its Breast Acoustic CT Scanner with Two Key Hires
NOVATO, Calif.--(BUSINESS WIRE)---- $QTI #BreastCancer--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health manage...
QT Imaging appoints Albright as Chief Science Officer
QT Imaging (QTI) announced the appointment of Julia Albright, Ph.D., as Chief Science Officer, CSO, effective July 27, 2026. Dr. Albright most recently served as Managing Director of the HIT…
QT Imaging Appoints Medical Imaging and Digital Health Executive Dr. Julia Albright as Chief Science Officer
NOVATO, Calif.--(BUSINESS WIRE)---- $QTI #BreastCancer--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health manage...
QT Imaging Holdings Announces Results of 2026 Annual Stockholder Meeting
NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (“QT Imaging” or the “Company”) (NASDAQ: QTI), a medical device company dedicated to transforming breast health management through innovative...
QT Imaging Holdings Transcript: AGM 2026
The meeting, held virtually, covered director elections, auditor ratification, and an equity plan amendment. All proposals passed with strong majorities, and governance procedures were followed, including certified voting and quorum establishment.
QT Imaging receives Israeli Ministry of Health registration
QT Imaging (QTI) Holdings announced that the Israeli Ministry of Health has granted registration for the Company’s scanner, authorizing commercialization of the system in Israel through February 2, 20...
QT Imaging Receives Israeli Ministry of Health Regulatory Registration
NOVATO, Calif.--(BUSINESS WIRE)---- $QTI #BreastCancer--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health manage...
QT Imaging completes first FDA routine inspection
QT Imaging (QTI) announced the successful completion of its first routine inspection by the FDA, with zero Form 483 observations. The FDA inspection reviewed QT Imaging’s Quality Management System and...
QT Imaging Announces Successful Completion of First FDA Routine Inspection with Zero Form 483 Observations
NOVATO, Calif.--(BUSINESS WIRE)---- $QTI #BreastCancer--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company engaged in the research, development, and comm...
QT Imaging Holdings Proxy statement: Proxy filing
QT Imaging Holdings filed a proxy statement on July 2, 2026, providing details for shareholder voting and corporate governance matters.
QT Imaging reports metrics for CTTM Scanner platform
QT Imaging (QTI) reported the characterization of repeatability and reproducibility metrics for quantitative biomarkers generated by its QT Imaging Breast Acoustic CTTM Scanner platform. The study dem...
A New Standard of Reproducibility for Quantitative Biomarkers in Breast Imaging
NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative...
QT Imaging Holdings Proxy statement: Proxy filing
QT Imaging Holdings filed a proxy statement on June 22, 2026, providing details for shareholder voting and corporate governance matters.
QT Imaging receives Saudi Arabia FDA regulatory clearance
QT Imaging (QTI) Holdings announced that its Breast Acoustic CT scanner has received official classification and clearance from the Kingdom of Saudi Arabia, KSA, for use as a medical device…
QT Imaging Receives Saudi Arabia FDA Regulatory Clearance
NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative...